Dr Ann Hayes

Ann Hayes worked for 22 years for GlaxoWellcome, initially in research, with particular expertise in the areas of CNS and pain. Before the GSK merger, she was a Director in Drug Discovery, and was involved in, determining the long-term Discovery strategy, portfolio management and discovery project management.

Ann left GSK in 2001 and set up a business as an independent pharmaceutical consultant. In this capacity she has co-founded three companies, Ionix Pharmaceuticals which has been bought by Vernalis, Therasci which has been bought by CeNeS, and Theradeas.

Ann is a non-executive director for Curidium Ltd and Plethora Solutions plc, and a member of the advisory boards for CeNeS, Paradigm, Ingenium and Neurosolutions. She has also held NED positions at Therasci, Ionix and Sirus (which was sold to Arakis). She currently consults regularly for CeNes and Shire, as well as doing ad hoc consulting for a number of small companies and VCs.